Compare · FRES vs ILMN
FRES vs ILMN
Side-by-side comparison of Fresh2 Group Limited (FRES) and Illumina Inc. (ILMN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both FRES and ILMN operate in Medical Specialities (Health Care), so they compete in similar markets.
- ILMN carries a market cap of $29.13B.
- ILMN has hit the wire 5 times in the past 4 weeks while FRES has been quiet.
- ILMN has more recent analyst coverage (25 ratings vs 0 for FRES).
- Company
- Fresh2 Group Limited
- Illumina Inc.
- Price
- $1.13-1.74%
- $192.63+4.36%
- Market cap
- -
- $29.13B
- 1M return
- -
- +18.83%
- 1Y return
- -
- +88.80%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- 2000
- News (4w)
- 0
- 5
- Recent ratings
- 0
- 25
Illumina Inc.
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has a collaboration agreement with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer. The company was incorporated in 1998 and is headquartered in San Diego, California.
Latest FRES
- SEC Form 6-K filed by Fresh2 Group Limited
- SEC Form 6-K filed by Fresh2 Group Limited
- Fresh2 Group Ltd. Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request A Hearing
- Fresh2 Group Ltd. Announces Receipt of an Additional Delinquency Compliance Alert Notice from Nasdaq
- SEC Form 6-K filed by Fresh2 Group Limited
- Fresh2 Has Partnered With Over 50 Influencers, Leveraging Key Partnerships To Fresh2's Video E-Commerce Business Is Rapidly Expanding Its Market Presence In The E-Commerce Sector
- Fresh2 Announces Collaboration with Over 50 Influencers in Video E-commerce
- Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
- Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending
- Fresh2 Group Limited Announces 1-For-10 Reverse ADS Split, Expected To Become Effective On July 10, 2024
Latest ILMN
- Illumina expands Billion Cell Atlas program with new AI drug developers
- Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026
- Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer
- Director Meister Keith A. was granted 142 shares, increasing direct ownership by 2% to 6,780 units (SEC Form 4)
- Director Ullem Scott B. was granted 167 shares, increasing direct ownership by 2% to 11,030 units (SEC Form 4)
- Bernstein resumed coverage on Illumina with a new price target
- Chief Legal Officer Davies Scott M sold $110,700 worth of shares (615 units at $180.00), decreasing direct ownership by 3% to 20,953 units (SEC Form 4)
- Director Skovronsky Daniel was granted 1,674 shares (SEC Form 4)
- SEC Form 3 filed by new insider Skovronsky Daniel
- Illumina Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits